Sg3 Management, LLC Arca Biopharma, Inc. Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.99 - $2.55 $75,034 - $96,150
-37,706 Closed
0 $0
Q3 2022

May 15, 2023
BUY
$2.13 - $25.68 $80,313 - $968,290
37,706 New
37,706 $80,000
Q3 2022

Nov 14, 2022
BUY
$2.13 - $25.68 $31,950 - $385,200
15,000 Added 66.06%
37,706 $78,000
Q2 2022

Aug 15, 2022
BUY
$2.2 - $2.53 $49,953 - $57,446
22,706 New
22,706 $57,000

Others Institutions Holding ABIO

# of Institutions
2
Shares Held
280K
Call Options Held
0
Put Options Held
0
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email